PROGRAM
WELCOME
Jay Walsh, PhD
Vice President for Research, Northwestern University
MODERATOR
Thomas V. O’Halloran, PhD
Founding Director, Chemistry of Life Processes Institute
Charles E. And Emma H. Morrison Professor, Departments of Chemistry and Molecular Biosciences, Weinberg College of Arts and Sciences, Professor of Medicine, Feinberg School of Medicine
FACULTY PRESENTERS
Vadim Backman, PhD
Walter Dill Scott Professor of Biomedical Engineering, McCormick School of Engineering; Professor, Biochemistry and Molecular Genetics and Medicine, Feinberg School of Medicine
“Developing novel strategies for chromatin regulation to fight resistance in cancer chemotherapy“
Susan E. Quaggin, MD
Charles H. Mayo, MD, Professor of Medicine;
Director, Feinberg Cardiovascular and Renal Research Institute;
Chief, Nephrology and Hypertension,
Department of Medicine, Feinberg School of Medicine
“A High 'TEK' Solution for Vascular Diseases”
Richard B. Silverman, PhD
Patrick G. Ryan/Aon Professor
Professor of Chemistry and Professor of Molecular Biosciences,
Weinberg College of Arts and Sciences
“Hepatocellular Carcinoma and ALS: Serious Unmet Medical Diseases Being Addressed in the Silverman Group”
Evan Scott, PhD
Assistant Professor of Biomedical Engineering; McCormick School of Engineering
“A Scalable Platform for Enhanced Delivery and Efficacy of Diverse Therapeutic and Diagnostic Agents”
Douglas E. Vaughan, MD
Chair, Department of Medicine; Irving S. Cutter Professor of Medicine; Professor of Medicine (Cardiology), Feinberg School of Medicine
“Targeting PAI-1: A Novel Approach to Delay the Multi-morbidity of Aging”
Teresa K. Woodruff, PhD
Thomas J. Watkins Professor of Obstetrics and Gynecology
and Dean, The Graduate School
“Oncofertility: From Bench to Bedside to Babies”
PANEL DISCUSSION
MODERATORS
Jay Olson, CFA Research Analyst Oppenheimer & Co.
Silvan Tuerkcan, PhD
Director
Oppenheimer & Co.
PANELISTS
Margarita Chavez, JD Managing Director AbbVie Ventures (ABBV)
Michael Margolis, RPh
Managing Director
Oppenheimer & Co.
Jim Sullivan, PhD
Venture Partner
OrbiMed
S. Edward Torres Founder and Managing Director Lilly Ventures
CORPORATE PRESENTERS
Brian Bernick, M.D., F.A.C.O.G. (WCAS'91)
Co-Founder and Director TherapeuticsMD (TXMD)
Andrew Chan, MD, PhD (WCAS'80)
Senior Vice President, Research Biology
Genentech (RHHBY)
Tassos E. Gianakakos (TGS'96)
Chief Executive Officer MyoKardia (MYOK)
Ankit Mahadevia, MD (WCAS’01)
President and CEO Spero Therapeutics (SPRO)
Chandler D. Robinson, MD (WCAS'06)
Co-Founder and Chief Executive Officer
Monopar Therapeutics
Sujal A. Shah (McC'95 McC'97)
President and Chief Executive Officer
CymaBay (CBAY) |